Advanced Pharma recalls magnesium sulfate solution for subpotent risk
Advanced Pharma recalls magnesium sulfate solution (NDC 42852-907-10) due to subpotent risk. This medication is for prescription use only and may not contain enough active ingredient.
Lower-risk recall
Subpotent
Contact the company
What happened, in plain English
Advanced Pharma is recalling a specific magnesium sulfate solution product because it may not contain enough active ingredient (subpotent). This could affect the treatment effectiveness if used as prescribed. Read more at govinfonow.com/recall/40955-advanced-pharma-recalls-magnesium-sulfate-solution-for-subpotent-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/40955-advanced-pharma-recalls-magnesium-sulfate-solution-for-subpotent-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0575-2018
Cite this page
“Advanced Pharma recalls magnesium sulfate solution for subpotent risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40955-advanced-pharma-recalls-magnesium-sulfate-solution-for-subpotent-risk. Based on FDA recall #D-0575-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0575-2018%22&limit=1).
Why it’s dangerous
The product may have insufficient magnesium sulfate concentration (subpotent), meaning it might not deliver the intended therapeutic effect. This could lead to inadequate treatment if used as directed for medical purposes.
Who’s affected
Prescription patients using this specific magnesium sulfate solution for medical treatment. Those with medical conditions requiring precise dosing are most at risk.
How to tell if you have this one
Check for the product name 'MAGnesium 2 gm in NS 100 mL Magnesium SULfate (USP) 0.9% Sodium Chloride (USP) in 100 mL Sterile single dose bag' on the label. The NDC code is 42852-907-10 and the lot number is 12/22/17 1422 108-90710P.
- Brand
Advanced Pharma- Category
Drug
What to do — step by step
Check Product Label
Look for the NDC code 42852-907-10 and lot number 12/22/17 1422 108-90710P on the sterile single-dose bag.
Where it went and when
Where it was distributed
Distributed in Texas.
FDA distribution: “Texas” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Texas.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class I
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0575-2018 (January 5, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0575-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.